Mark P. Colonnese

Biota Pharmaceuticals

Former Executive Vice President and Chief Financial Officer

Overview

Mark P. Colonnese received an average compensation of $665,774 at Biota Pharmaceuticals from 2016 to 2018.

Annual data

2018

Salary$43,725
Other$595,656
Total$639,381

In 2018, Mark P. Colonnese earned a total compensation of $639,381 as Former Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals.

Colonnese received $595,656 in other compensation, which accounts for 93.16% of total compensation.

Colonnese also received $43,725 in salary.

2017

Option Awards$226,754
Salary$349,800
Other$31,442
Total$607,996

In 2017, Mark P. Colonnese earned a total compensation of $607,996 as Former Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals.

Colonnese received $349,800 in salary, which accounts for 57.53% of total compensation.

Colonnese also received $226,754 in option awards and $31,442 in other compensation.

2016

Non-Equity Incentive Plan$48,400
Option Awards$291,713
Salary$233,750
Other$176,082
Total$749,945

In 2016, Mark P. Colonnese earned a total compensation of $749,945 as Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals.

Colonnese received $291,713 in option awards, which accounts for 38.90% of total compensation.

Colonnese also received $48,400 in non-equity incentive plan, $233,750 in salary and $176,082 in other compensation.

Transgenomic

Executive Vice President and Chief Financial Officer

Overview

Annual data

2012

Option Awards$198,250
Salary$96,106
Other$2,056
Total$296,412

In 2012, Mark P. Colonnese earned a total compensation of $296,412 as Executive Vice President and Chief Financial Officer at Transgenomic.

Colonnese received $198,250 in option awards, which accounts for 66.88% of total compensation.

Colonnese also received $96,106 in salary and $2,056 in other compensation.